SPOTLIGHT -
FDA approves two Type 2 Diabetes drugs for use in children
FDA approves Jardiance and Synjardy for pediatric use.
Insulin cost cap bill proposed, garners praise and caution
A bipartisan Senate bill, Affordable Insulin Now Act of 2023, would require plans to cover insulin for no more than $35 per month.
PBM association begins ad campaign to defend industry's role
The ads focus on how PBMs promote competition in the prescription drug marketplace and provide choice for employers.
Physicians can take steps to protect their families from COVID-19
Six tips for protecting yourself and your family during the pandemic
